Characteristics | Total (n = 832) | with OAC (n = 301) | without OAC (n = 531) | P value |
---|---|---|---|---|
Age (mean ± SD) | 78 ± 6.7 | 77 ± 6.1 | 78 ± 6.9 | 0.000 |
Female (n, %) | 351(42.2) | 135(44.9) | 216(40.7) | 0.244 |
BMI (mean ± SD) | 24.7 ± 3.8 | 25.2 ± 3.5 | 24.3 ± 3.9 | 0.001 |
Comorbidity (n, %) | ||||
Hypertension | 630(75.7) | 228(75.7) | 402(75.7) | 1.000 |
Hyperlipidemia | 171(20.6) | 59(19.6) | 112(21.1) | 0.656 |
Diabetes | 227(27.3) | 80(26.6) | 147(27.7) | 0.747 |
Heart failure | 307(36.9) | 86(28.6) | 221(41.6) | 0.000 |
Chronic obstructive pulmonary disease | 38(4.6) | 6(2.0) | 32(6.0) | 0.009 |
Renal Insufficiency | 121(14.5) | 26(8.6) | 95 (17.9) | 0.000 |
Chronic Renal Insufficiency | 95(11.4) | 20(6.6) | 75(14.1) | 0.001 |
Malignant Tumor | 116(13.9) | 34(11.3) | 82(15.4) | 0.097 |
Type of atrial fibrillation (n, %) | ||||
Paroxysmal | 383(46.0) | 128(42.5) | 255(48.0) | 0.129 |
Persistent | 178(21.4) | 75(24.9) | 103(19.4) | 0.065 |
Unclassified | 271 | 98 | 173 | |
History (n, %) | ||||
Previous myocardial infarction | 108(13.0) | 20(6.6) | 88(16.6) | 0.000 |
Previous stroke | 211(25.4) | 66(21.9) | 145(27.3) | 0.097 |
Previous bleeding | 32(3.8) | 13(4.3) | 19(3.6) | 0.580 |
Concomitant medication (n, %) | ||||
Statins | 633(76.1) | 252(83.7) | 381(71.8) | 0.000 |
β-blockers | 611(73.4) | 238(79.1) | 373(70.2) | 0.006 |
ACEI | 200(24.0) | 62(20.6) | 138(26.0) | 0.091 |
ARB | 349(41.9) | 142(47.2) | 207(39.0) | 0.023 |
Diuretics | 475(57.1) | 146(48.5) | 329(62.0) | 0.000 |
Calcium Antagonists | 448(53.8) | 167(55.5) | 281(52.9) | 0.515 |
PPI | 217(26.1) | 143(47.5) | 204(38.4) | 0.013 |
APT | 389(46.8) | 159(52.8) | 230(43.3) | 0.009 |